Global HPV Testing and PAP Test Market to Reach $5.37 Billion with a CAGR of 6.26% – QNT Press Release

DUBLIN, Sept. 14, 2022 /PRNewswire/ — The “HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to’s offering.

The global HPV testing and PAP test market reached a value of US$ 3.73 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 5.37 Billion by 2027, exhibiting a CAGR of 6.26% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test.

These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in certificates.

HPV Testing…

Full story available on

Source link

Recommended For You

About the Author: News Center